G
GraphWear Technologies
The world's first needle free continuous health monitoring platform
About GraphWear Technologies
GraphWear Technologies is pioneering non-invasive glucose monitoring solutions using advanced nanotechnology. The company operates in the healthcare technology market, focusing on providing a pain-free alternative to traditional blood tests for glucose level monitoring. GraphWear's core product, Bios, is designed to detect biomolecules from the surface of the skin, eliminating the need for needles. This technology is currently in clinical testing and aims to serve individuals with diabetes and other chronic conditions requiring regular glucose monitoring. The business model revolves around selling the Bios device and potentially offering subscription-based services for continuous monitoring and data analytics. Revenue is generated through direct sales to consumers and partnerships with healthcare providers. GraphWear's innovative approach positions it to disrupt the traditional glucose monitoring market by offering a more convenient and less invasive solution.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- San Francisco, United States
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 61.0/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Remote Monitoring, Spinout, Wearable, Tech for Patients, remote health monitoring, DT and LS
- Technology
- Deep Tech, Connected Device
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Oct 2021 | $21M | $82M | Builders VC · Mission BioCapital · VSC Ventures · Mayfield | — |
| SERIES A✓Equity / VC | Apr 2018 | $4.2M | $17M | Mission Bay Capital · Mission BioCapital | — |
Growth signals
Latest recorded traffic for GraphWear Technologies is 1.8K monthly website visits, up 50% over the last three months. GraphWear Technologies's team declined 33.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
DreamIt Health
Series A5 investors entered at this stage
Mission BioCapital
Mission Bay Capital
Mayfield
Builders VC
VSC Ventures
Other known investors3 additional known investors
University of Pennsylvania
MBC Biolabs
Plug and Play
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about GraphWear Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GraphWear Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.